| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.07 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.37 | 0.07 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |